Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cross-Protection against Marburg Virus Strains by Using a Live, Attenuated Recombinant Vaccine

14 Sept 2006

Abstract excerpt

Marburg virus (MARV) has been associated with sporadic episodes of hemorrhagic fever, including a recent highly publicized outbreak in Angola that produced severe disease and significant mortality in infected patients. MARV is also considered to have potential as a biological weapon. Recently, we reported the development of a promising attenuated, replication-competent vaccine against MARV based on recombinant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Viral Infections and Outbreaks Research
Share to Viral Infections and Vectors

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 16973570
DOI: 10.1128/jvi.00959-06

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cross-Protection against Marburg Virus Strains by Using a Live, Attenuated Recombinant VaccinePMID 16973570Read ↗

Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman PrimatesSemantic proximity Read ↗

A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challengeSemantic proximity Read ↗

Rapid and Durable Protection Against Marburg Virus with a Single-Shot ChAd3-MARV GP VaccineSemantic proximity Read ↗

Vaccinomics strategy for developing a unique multi-epitope monovalent vaccine against Marburg marburgvirusSemantic proximity Read ↗

Discovery of potent cross-neutralizing antibodies for the treatment of Marburg virus diseaseSemantic proximity Read ↗

Induction of Broad Cytotoxic T Cells by Protective DNA Vaccination Against Marburg and EbolaSemantic proximity Read ↗

Distinct Biological Phenotypes of Marburg and Ravn Virus Infection in Macaques.Semantic proximity Read ↗

A hamster model for Marburg virus infection accurately recapitulates Marburg hemorrhagic fever.Semantic proximity Read ↗

A MOPEVAC multivalent vaccine induces sterile protection against New World arenaviruses in non-human primatesSemantic proximity Read ↗

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsSemantic proximity Read ↗

Single Immunization With a Monovalent Vesicular Stomatitis Virus–Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundibugyo ebolavirusSemantic proximity Read ↗

Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman PrimatesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.